Mackenzie Financial
MRVI icon

Mackenzie Financial’s Maravai LifeSciences MRVI Stock Holding History

Mackenzie Financial’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-6,306,425
Closed -$17.8M – 1646
2026
Q1 		$17.8M Buy
6,306,425
+132,769
+2% +$450K 0.02% 427
2025
Q4 		$20.1M Buy
6,173,656
+104,355
+2% +$351K 0.02% 384
2025
Q3 		$17.4M Hold
6,069,301
– – 0.02% 404
2025
Q2 		$14.6M Sell
6,069,301
-44,321
-0.7% -$93.2K 0.02% 418
2025
Q1 		$13.5M Sell
6,113,622
-69,094
-1% -$273K 0.02% 412
2024
Q4 		$33.7M Sell
6,182,716
-180,696
-3% -$1.16M 0.05% 265
2024
Q3 		$52.9M Buy
6,363,412
+502,771
+9% +$4.35M 0.07% 218
2024
Q2 		$42M Buy
5,860,641
+844,325
+17% +$7.29M 0.06% 236
2024
Q1 		$43.5M Sell
5,016,316
-152,860
-3% -$1.03M 0.06% 235
2023
Q4 		$33.9M Buy
5,169,176
+238,335
+5% +$1.54M 0.05% 258
2023
Q3 		$48.7M Buy
4,930,841
+1,384,455
+39% +$15.2M 0.08% 195
2023
Q2 		$44.1M Buy
3,546,386
+1,008,824
+40% +$13.6M 0.07% 228
2023
Q1 		$35.6M Buy
2,537,562
+416,401
+20% +$5.98M 0.05% 260
2022
Q4 		$30.4M Buy
2,121,161
+2,070,193
+4,062% +$32.6M 0.05% 268
2022
Q3 		$1.3M Buy
+50,968
New +$1.28M ﹤0.01% 779

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Mackenzie Financial's MRVI Position: Q2 2026 in Review

Mackenzie Financial sold out of Maravai LifeSciences (MRVI) in Q2 2026, closing a stake of 6,306,425 shares — an estimated $17.8M sold.

Mackenzie Financial first reported a position in MRVI in Q3 2022 and held it in 15 quarters. The position peaked at $52.9M in Q3 2024. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • Mackenzie Financial reported no remaining Maravai LifeSciences position as of Q2 2026 after selling out during the quarter.
  • Mackenzie Financial sold 6,306,425 Maravai LifeSciences shares in Q2 2026, an estimated $17.8M.
  • Mackenzie Financial first reported a position in Maravai LifeSciences in Q3 2022 and held it in 15 quarters.
  • Mackenzie Financial's Maravai LifeSciences position peaked at $52.9M in Q3 2024.
  • 178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Mackenzie Financial's 13F filing for Q2 2026, filed 13 Aug 2026.